Skip to content

Vienna Hypothermic Oxygenated Machine Perfusion Study

Vienna Hypothermic Oxygenated Machine Perfusion for Liver Transplantation Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06418165
Acronym
VIHOMPS
Enrollment
500
Registered
2024-05-17
Start date
2018-01-01
Completion date
2038-12-31
Last updated
2024-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Liver Disease, Hepatocellular Carcinoma

Keywords

Liver Transplantation, Hypothermic Oxygenated Machine Perfusion

Brief summary

In this observational cohort study data on all patients undergoing liver transplantation after hypothermic oxygenated machine perfusion at Medical University of Vienna will be prospectively recorded. Investigation of short- and long-term outcome in this cohort will be conducted.

Interventions

None listed

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing liver transplantation with the use of hypothermic oxygenated machine perfusion * age ≥ 18 years

Exclusion criteria

* pregnancy * partial grafts * the anatomical integrity of the liver is not preserved in a way that makes the perfusion of the liver possible

Design outcomes

Primary

MeasureTime frameDescription
Incidence of ischemic-type biliary lesionsWithin one year after liver transplantationNon-anastomotic stenosis, post-transplant cholangiopathy

Secondary

MeasureTime frameDescription
Rate of early allograft dysfunctionEvaluated within the first 7 postoperative daysDeviation of bilirubin, transaminases or international normalised ratio
Rate of primary non-functionEvaluated in the immediate postoperative period, specifically within the first postoperative week
Incidence of re-transplantationEvaluated in the immediate postoperative period, specifically within the first postoperative week

Countries

Austria

Contacts

Primary ContactDavid Pereyra, MD, PhD
david.pereyra@muv.ac.at+4314040056210
Backup ContactJule Dingfelder, MD
jule.dingfelder@muv.ac.at+4314040056210

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026